* Aspira Women's Health Inc AWH.OQ AWH.O is expected
to show a
rise in quarterly revenue when it reports results on November
10.
* The Austin Texas-based company is expected to report a
47.1% increase in revenue to $2.45 million from $1.67 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Aspira Women's
Health Inc
is for a loss of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aspira
Women's
Health Inc is $3, above its last closing price of $0.39.
This summary was machine generated November 8 at 16:19 GMT. All
figures in US dollars unless otherwise stated